AZBIO Member Guest Posts
Flagship Biosciencs expands quantitative histopathology services into neurodegenerative disease and neurotoxicity
Stereological and classical image analysis approaches help to more accurately quantify neuropathology and model treatment efficacyContinue reading
Dancer Mia Welch Bridged to Heart Transplant with SynCardia Total Artificial HeartContinue reading
Flagship Biosciences, a fast growing pharmaceutical services company based in Flagstaff, AZ, is a leading example of the power of the collaborative nature of the Arizona bioindustry.Continue reading
Flagship Biosciences acquires IHCtech, a leading provider of research immunohistochemistry and histology services
Combining tissue analysis with expert immunohistochemistry completes Flagship’s novel quantitative pathology approachesContinue reading
Freedom® Portable Driver for Powering SynCardia’s Total Artificial Heart Honored in Critical Care and Emergency Medicine Category
SynCardia Systems, Inc., the privately-held manufacturer of the world’s first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that the company’s Freedom® portable driver, the world’s first wearable power supply for the SynCardia temporary Total Artificial Heart, was selected as the Bronze Winner in the Critical Care and Emergency Medicine category of the 2012 Medical Design Excellence Awards (MDEA) on May 23 in Philadelphia.
“It is an honor to have the premier competition for medical device design and innovation recognize the achievements of our Freedom portable driver,” said Michael Garippa, SynCardia Chairman/CEO/President. “For the first time in U.S. history, the Freedom portable driver is allowing stable patients without human hearts to leave the hospital and resume their lives at home while they wait for a matching donor heart. The Freedom driver is pivotal in the Total Artificial Heart becoming the new standard of care for end-stage biventricular heart failure.”
Weighing 13.5 pounds, the Freedom portable driver is designed to be worn by the patient in the Freedom Backpack or Shoulder Bag. The Freedom driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S. More than 80 patients worldwide have been supported by the Freedom driver, accounting for more than 30 patient years of support.
MDEA entries were evaluated on the basis of their design and engineering features, including… read more at SynCardia.com
Total Artificial Heart Replaces Left Ventricular Assist Devices in 7 Patients With Total Artificial Heart.
Two Patients Bridged to Transplant, Five Currently Waiting for a Donor HeartContinue reading
Arbsource earns $150,000 from the Department of Energy for product developmentContinue reading
Cancer Prevention Pharmaceuticals Awarded Arizona Innovation ChallengeContinue reading
Roy Parker is renowned for his work on the cellular machinery that translates genetic information into proteins.
The history of the universe is becoming clearer thanks to the field of infrared astronomy and the contributions of Marcia J. Rieke.Continue reading
Identifying diseases at an early, presymptomatic stage may offer the best chance for establishing proper treatment and improving patient outcomes. A new technique known as immunosignaturing harnesses the human immune system as an early warning sentry – one acutely sensitive to changes in the body that may be harbingers of illness.Continue reading